ARCHIVES

Reports On AACR Scientific Sessions

This article is from The Cancer Letter archive.

Vol. 02 No. 21 | May 21, 1976

Download PDF Visit The Full Archive

Related Articles

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

NCI Programs:Institute Informs Public About Thyroid Cancer Risk From Fallout.

January 3, 2003

ACS Reorganization Plans, Policy Changes Discussed By Board

November 29, 1991

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

Clinical Trials Approved By NCI Last Month

March 29, 2002